AU1721801A - Method for the preparation of purified hcv rna by exosome separation - Google Patents

Method for the preparation of purified hcv rna by exosome separation

Info

Publication number
AU1721801A
AU1721801A AU17218/01A AU1721801A AU1721801A AU 1721801 A AU1721801 A AU 1721801A AU 17218/01 A AU17218/01 A AU 17218/01A AU 1721801 A AU1721801 A AU 1721801A AU 1721801 A AU1721801 A AU 1721801A
Authority
AU
Australia
Prior art keywords
preparation
hcv rna
purified hcv
exosome separation
separation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17218/01A
Other languages
English (en)
Inventor
Sergio Abrignani
Piero Pileri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Publication of AU1721801A publication Critical patent/AU1721801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU17218/01A 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation Abandoned AU1721801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9927320 1999-11-18
GBGB9927320.3A GB9927320D0 (en) 1999-11-18 1999-11-18 Exosome separation
PCT/IB2000/001801 WO2001036601A1 (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation

Publications (1)

Publication Number Publication Date
AU1721801A true AU1721801A (en) 2001-05-30

Family

ID=10864765

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17218/01A Abandoned AU1721801A (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation

Country Status (13)

Country Link
US (2) US7198923B1 (OSRAM)
EP (1) EP1230347B1 (OSRAM)
JP (1) JP4675017B2 (OSRAM)
AT (1) ATE373084T1 (OSRAM)
AU (1) AU1721801A (OSRAM)
CA (1) CA2392075C (OSRAM)
CY (1) CY1107521T1 (OSRAM)
DE (1) DE60036403T2 (OSRAM)
DK (1) DK1230347T3 (OSRAM)
ES (1) ES2292489T3 (OSRAM)
GB (1) GB9927320D0 (OSRAM)
PT (1) PT1230347E (OSRAM)
WO (1) WO2001036601A1 (OSRAM)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US20080268429A1 (en) * 2004-06-02 2008-10-30 Sourcepharm, Inc. Rna - Containing Microvesicles and Methods Therefor
CA3061952C (en) * 2006-03-09 2022-07-19 Aethlon Medical, Inc. Extracorporeal removal of microvesicular particles
US9085778B2 (en) 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
US8617806B2 (en) * 2008-01-25 2013-12-31 Hansabiomed Ou Method to measure and characterize microvesicles in the human body fluids
ES2936256T3 (es) * 2008-02-01 2023-03-15 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
WO2014057128A2 (en) 2012-10-11 2014-04-17 Vin-De-Bona Trading Company Pte Ltd Method of painting microvesicles
US11266736B2 (en) 2008-04-17 2022-03-08 Vin De Bona Trading Company Pte Ltd Method of painting micro vesicles
AU2009259893A1 (en) * 2008-06-20 2009-12-23 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US9487837B2 (en) 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
CN102308004A (zh) 2008-10-30 2012-01-04 卡里斯生命科学卢森堡控股有限责任公司 评价rna图案的方法
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
EP2419144B1 (en) 2009-04-17 2019-08-07 Oxford University Innovation Limited Composition for delivery of genetic material
BRPI0900815A2 (pt) * 2009-04-23 2010-12-28 Sociedade Benef Israelita Bras Hospital Albert Einstein método para isolamento de exossomos a partir de soluções biológicas utilizando nanopartìculas de óxido de ferro
IN2012DN00866A (OSRAM) 2009-07-16 2015-07-10 Gen Hospital Corp
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011049059A1 (ja) * 2009-10-22 2011-04-28 国立大学法人岐阜大学 Ｒｎａ内包キャリア組成物
US20130203061A1 (en) 2009-11-30 2013-08-08 Michael KLASS Methods and systems for isolating, storing, and analyzing vesicles
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
WO2011156763A1 (en) 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Methods for characterizing kidney function
EP2591359B1 (en) 2010-07-07 2017-03-01 Aethlon Medical Inc Methods for quantifying exosomes
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2638057B1 (en) 2010-11-10 2019-03-06 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
ES2744589T3 (es) 2011-05-11 2020-02-25 Exosome Diagnostics Inc Extracción de ácido nucleico de materiales biológicos heterogéneos
JP5823031B2 (ja) 2011-06-10 2015-11-25 日立化成株式会社 小胞捕捉デバイスおよびそれを用いるための方法
EP2723865B1 (en) 2011-06-21 2019-03-27 Alnylam Pharmaceuticals, Inc. METHODS FOR DETERMINING ACTIVITY OF RNAi IN A SUBJECT
WO2013028788A1 (en) 2011-08-22 2013-02-28 Exosome Diagnostics, Inc. Urine biomarkers
HK1199754A1 (en) * 2011-09-22 2015-07-17 Universidad De Los Andes Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage
US10174361B2 (en) 2011-11-10 2019-01-08 Exosome Diagnostics, Inc. Cerebrospinal fluid assay
GB201121070D0 (en) 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
EP2875348B1 (en) * 2012-07-19 2018-09-26 Atlantic Cancer Research Institute Method for the isolation of microvesicles
EP2890783A4 (en) 2012-08-30 2016-03-02 Exosome Diagnostics Inc WITNESSES FOR NUCLEIC ACID ASSAYS
CN105025878A (zh) 2012-10-03 2015-11-04 外来体诊断公司 微泡在医学疾病和病况的诊断、预后和治疗中的用途
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
US20150353920A1 (en) 2013-01-03 2015-12-10 Exosome Diagnostics, Inc. Methods for isolating microvesicles
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
CA2906502A1 (en) 2013-03-13 2014-10-02 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
JP6297676B2 (ja) 2013-05-06 2018-03-20 日立化成株式会社 標的分子を捕捉するためのデバイス及び方法
US10301681B2 (en) 2013-08-06 2019-05-28 Exosome Diagnostics, Inc. Methods of treating a subject with a high gleason score prostate cancer
WO2015031694A2 (en) 2013-08-28 2015-03-05 Caris Science, Inc. Oligonucleotide probes and uses thereof
TWI788704B (zh) * 2013-10-24 2023-01-01 美商納諾索米克斯公司 分析個體樣品之方法
WO2015112382A1 (en) * 2014-01-21 2015-07-30 Morehouse School Of Medicine Exosome-mediated detection of infections and diseases
US10844436B2 (en) 2014-04-01 2020-11-24 Cornell University Use of double-stranded DNA in exosomes: a novel biomarker in cancer detection
US11268085B2 (en) 2014-05-27 2022-03-08 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
US10465183B2 (en) 2014-07-09 2019-11-05 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
EP3808756A1 (en) 2014-07-17 2021-04-21 The Trustees of The University of Pennsylvania Methods for using exosomes to monitor transplanted organ status
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
US10370719B2 (en) 2014-11-12 2019-08-06 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
AU2016229076B2 (en) 2015-03-09 2022-01-20 Caris Science, Inc. Oligonucleotide probes and uses thereof
IL256175B2 (en) 2015-06-10 2024-10-01 Univ Texas Using exosomes to treat the disease
IL318703A (en) 2015-06-29 2025-03-01 Caris Science Inc Therapeutic oligonucleotides
EP3328873B1 (en) 2015-07-28 2025-09-17 Caris Science, Inc. Targeted oligonucleotides
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法
EP3165926A1 (en) 2015-11-06 2017-05-10 Humanitas Mirasole S.p.A. Method for characterization of cell specific microvesicles
WO2017181161A1 (en) 2016-04-15 2017-10-19 Predicine, Inc. Systems and methods for detecting genetic alterations
US20190093172A1 (en) 2016-04-15 2019-03-28 Exosome Diagnostics, Inc. Plasma-based detection of anaplastic lymphoma kinase (alk) nucleic acids and alk fusion transcripts and uses thereof in diagnosis and treatment of cancer
EP4299803A3 (en) 2016-05-02 2024-03-27 Encodia, Inc. Macromolecule analysis employing nucleic acid encoding
EP3452613B1 (en) 2016-05-05 2021-12-29 Exosome Diagnostics, Inc. Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection
CN109642229A (zh) 2016-05-13 2019-04-16 外来体诊断公司 从生物液体分离细胞外囊泡和共分离无细胞dna的自动和手动方法
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
US11174503B2 (en) 2016-09-21 2021-11-16 Predicine, Inc. Systems and methods for combined detection of genetic alterations
WO2018055080A1 (en) 2016-09-22 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
US11396676B2 (en) 2016-10-21 2022-07-26 Exosome Diagnostics, Inc. Sequencing and analysis of exosome associated nucleic acids
EP3548635B1 (en) 2016-11-30 2021-04-28 Exosome Diagnostics, Inc. Methods to detect mutations in plasma using exosomal rna and cell free dna from non-small cell lung cancer patients
GB2559319B (en) 2016-12-23 2019-01-16 Cs Genetics Ltd Reagents and methods for the analysis of linked nucleic acids
US20200149036A1 (en) 2017-01-02 2020-05-14 Exosome Diagnostics, Inc. Methods to distinguish rna and dna in a combined preparation
BR112019023772A2 (pt) 2017-05-12 2020-06-09 Evonik Operations Gmbh método para detectar doenças induzidas por c. perfringens em animais e kit de diagnóstico
JP7225121B2 (ja) 2017-05-17 2023-02-20 エクソサム ダイアグノスティクス，インコーポレイティド 微小胞核酸および／またはタンパク質、並びに腎移植拒絶反応マーカーとしてのその使用
EP3652315A4 (en) * 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
EP3655531B1 (en) 2017-07-18 2024-09-04 Exosome Diagnostics, Inc. Sequencing of nucleic acids associated with exosomal isolation from patients with glioblastoma multiforme
AU2018358057B2 (en) 2017-10-31 2023-03-02 Encodia, Inc. Kits for analysis using nucleic acid encoding and/or label
US20200339987A1 (en) 2017-11-09 2020-10-29 Alnylam Pharmaceuticals, Inc. Assays and methods for determining expression of the lect2 gene
CN110123838B (zh) * 2018-02-02 2022-04-01 上海睿泰生物科技股份有限公司 负载白藜芦醇的人多能干细胞外泌体及其制备方法与用途
CN110123841A (zh) * 2018-02-09 2019-08-16 上海市第六人民医院 负载白藜芦醇的人多能干细胞外泌体在制备治疗生殖系统疾病药物的用途
US20210011027A1 (en) 2018-03-02 2021-01-14 Evonik Operations Gmbh In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
CN112739832B (zh) 2018-06-06 2024-06-04 外来体诊断公司 用于开发尿液生物标志物和用于检测膀胱癌的方法
WO2020106853A1 (en) 2018-11-20 2020-05-28 Exosome Diagnostics, Inc. Compositions and methods for internal controls of microvesicle isolations
MX2021006917A (es) 2018-12-14 2021-07-07 Evonik Operations Gmbh Procedimiento in vitro para la deteccion de disbiosis intestinal aviar.
CN114072499B (zh) 2019-04-30 2024-08-06 Encodia公司 用于制备分析物的方法和相关试剂盒
EP4031865A2 (en) * 2019-09-18 2022-07-27 Exosome Diagnostics, Inc. Compositions, methods, and kits for the isolation of extracellular vesicles
CN115666619A (zh) 2020-04-13 2023-01-31 埃索普罗瑟医疗有限公司 用于抗病毒治疗的包含野生型p53蛋白的细胞衍生囊泡
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
TW202214851A (zh) * 2020-10-07 2022-04-16 國立中央大學 外泌體核酸萃取方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
GB9416671D0 (en) 1994-08-17 1994-10-12 Biocine Spa Assay
CA2225553A1 (en) * 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
GB9517926D0 (en) 1995-09-01 1995-11-01 Biocine Spa Binding protein
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
ATE449847T1 (de) 1997-10-06 2009-12-15 Novartis Vaccines & Diagnostic Hepatitis c rezeptorprotein cd81
AU756303B2 (en) 1997-11-06 2003-01-09 Innogenetics N.V. Host derived proteins binding HCV: medical, diagnostic and purification use
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation

Also Published As

Publication number Publication date
EP1230347A1 (en) 2002-08-14
JP4675017B2 (ja) 2011-04-20
ES2292489T3 (es) 2008-03-16
GB9927320D0 (en) 2000-01-12
ATE373084T1 (de) 2007-09-15
DK1230347T3 (da) 2007-11-05
US7807438B2 (en) 2010-10-05
CA2392075A1 (en) 2001-05-25
DE60036403T2 (de) 2008-06-12
WO2001036601A1 (en) 2001-05-25
PT1230347E (pt) 2007-12-20
JP2003514523A (ja) 2003-04-22
CA2392075C (en) 2011-01-04
US7198923B1 (en) 2007-04-03
US20070254351A1 (en) 2007-11-01
CY1107521T1 (el) 2013-03-13
DE60036403D1 (de) 2007-10-25
EP1230347B1 (en) 2007-09-12

Similar Documents

Publication Publication Date Title
GB9927320D0 (en) Exosome separation
AU2002360592A1 (en) Inhibitors of hepatitis c virus
WO2002060926A3 (en) Hepatitis c tripeptide inhibitors
AU4203201A (en) Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
WO2004032827A3 (en) Hepatitis c virus inhibitors
DE60334205D1 (en) Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
AU4358701A (en) Methods of preventing and treating respiratory viral infeciton using immunomodulatory polynucleotide sequences
DE60324552D1 (en) Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
AU2692900A (en) Treatment of disease
HUP0300121A3 (en) Macrocyclic peptides active against the hepatitis c virus, process for preparation and pharmaceutical compositions containing them
WO2002014362A3 (en) A hepatitis c virus non-structural ns3/4a fusion gene
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
WO2003015708A3 (en) Composition and method for treating hiv infection
AUPP971399A0 (en) Separation of plasma components
WO2004089983A3 (en) Severe acute respiratory syndrome (sars) causing coronavirus
HK1042116A1 (zh) 淨化或隔離過濾病毒核酸的方法
WO2003053332A3 (en) Composition and method for treating viral infection
WO2001017537A3 (en) Methods and compositions for reducing immune response
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
EP1057889A4 (en) IMPROVED IMMUNOGEN FOR INACTIVATED VACCINE AGAINST INFECTION WITH JAPANESE ENCEPHALITIS VIRUSES AND METHOD FOR THE PRODUCTION THEREOF
WO2002087600A8 (de) Verwendung von phyllanthusbestandteilen zur behandlung oder prophylaxe von infekten durch hepatitis b-viren
EP0868536A4 (en) GENETIC SUPPRESSOR ELEMENTS AGAINST HIV
WO2003017943A3 (en) Therapeutic compositions and methods for treating viral infection
AU4952393A (en) New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
AU2003253255A1 (en) An immunodeficiency virus (hiv) dna vaccine and to the process of preparation thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase